What this study is
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
What's being tested
- Flu shot
Intervention · BIOLOGICAL
All participants will receive a single shot of the flu vaccine
Study details
- Sponsor
- Stanford University
- Conditions
- Corona Virus Infection · Flu Vaccine · Immunity
- Enrolling
- 230 people
- Starts
- 2020-10-29
- Est. completion
- 2028-04
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 9 Years – 64 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Age 9 through 64 years
- Diagnosed with COVID-19 at least 2 months prior enrollment
- Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
- Patients without COVID-19 diagnosis for controls
You can't join if
- Received the influenza vaccine less than 4 months ago
- Pregnant or lactating
- Patients with special risks attendant to venipuncture
- Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment
- Contraindication to the flu vaccine
- Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openStanford University
Palo Alto, California, United States
- SNP Center Inquiry · Contact(650) 521-7237snpcenterallergy_inquiry@stanford.edu
Recruiting
Study team
Sponsor
Stanford University
Study ID IRB-58356
Principal investigator
Sayantani Sindher, MD
Stanford University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.